搜索
搜索

SERVICES

研发服务

● 肿瘤微环境多维度分析 ▶

微信截图_20210820093155
产品描述

Introduction

To understand the complex tissue microenvironment under both physiological and pathological conditions such as cancer, it is very important to profile immune checkpoint proteins and phenotypic markers. Spatial localization, co-localization, and proximity of multiple biomarkers are critical when cataloging subsets of tumor infiltrating lymphocytes and cancer cells as well as their interactions in the tumor microenvironment.

Based on T cell-​based​ classification​ of ​tumours, cancers are defined as four classification: hot immune tumours, altered-​immunosuppressed immune ​tumours, ​altered-​excluded immune ​tumours, cold immune tumours. It is becoming critical to understand the mechanisms responsible for hot, altered or cold immune tumours in order to boost a weak antitumour immunity. Both current and potential therapeutic strategies to best target these four categories of tumour, which in most cases involve combinatorial immunotherapy strategies. 

 

From: Nature reviews | Drug Discovery

 

 

Multidimensional Analysis of Tumor Microenvironment at Yicon

 

A.

B.

Fig.1 IHC staining of human lymphocytes (hCD45 positive) in PBMC humanized xenograft tumors ( A. PBMCCDX xenografts.  B. PBMCPDX xenografts.) at Yicon.

 

 

 

 

 

Fig.2 Expression of Immune Suppression Genes in TME of PBMC Humanized Models.

 

 

A.

B.

 

Fig.3 A. Immune checkpoint receptor phenotypes in TME. B. Digital quantification of multiple IHC in TME.

 

 

 

Fig.4 IHC staining of the predictive biomarker in patient samples.

上一个
下一个

关于我们   |   研发服务   |   技术平台   |   新闻中心   |   加入我们   |   联系我们

联系我们

地址:北京经济技术开发区隆庆街9号1号楼
邮编:100176
电话:
+86(10)6786-4680

邮箱:HR@yiconmed.com

亦康医药

扫一扫,关注我们

版权所有:亦康(北京)医药科技有限公司   备案号:京ICP备20016765号-1

网站建设:中企动力 北二分

亦康医药